The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives

SIMPLE SUMMARY: In recent years, prognosis of non-small cell lung cancer (NSCLC) patients significantly improved thanks to the introduction of tyrosine kinase inhibitors (TKIs) in clinical practice. ALK-rearranged NSCLC patients benefit from treatment with ALK inhibitors (ALK-i), which have shown a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cognigni, Valeria, Pecci, Federica, Lupi, Alessio, Pinterpe, Giada, De Filippis, Chiara, Felicetti, Cristiano, Cantini, Luca, Berardi, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563286/
https://www.ncbi.nlm.nih.gov/pubmed/36230686
http://dx.doi.org/10.3390/cancers14194765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563286/
https://www.ncbi.nlm.nih.gov/pubmed/36230686
http://dx.doi.org/10.3390/cancers14194765

Ejemplares similares